尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Deliargyris Efthymios. Officer active across 1 company, notably Cytosorbents Corp. Cumulatively, 6 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €28k. Activity tracked since 10 August 2022. The latest transaction was filed on 8 August 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Deliargyris Efthymios is a declarant linked to Cytosorbents Corp, where the listed role is Chief Medical Officer. He has 6 filings in total, and in the 6 sampled recent filings, the recorded transactions run from 2022-08-12 to 2025-08-08, with EUR 27782 of buys and EUR 0 of sells, and the most common transaction nature is Attribution.